The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
Open accessAbstract
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. The long-term impact of HCV infection is highly variable, from minimal changes to extensive fibrosis and cirrhosis with or without hepatocellular carcinoma (HCC). The number of chronically infected persons worldwide is estimated to be about 160 million, but most of them are unaware of their infection. The implementation of extended criteria for screening of HCV, such as targeting birth cohorts, is the subject of major debate among different stakeholders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,836
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Poordad, F., McCone, J., Bacon, B. R., Bruno, S., Manns, M. P., Sulkowski, M. S., Jacobson, I. M., Reddy, K. R., Goodman, Z. D., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010494 · Cited by 2,520
Castéra, L., Vergniol, J., Foucher, J., Le Bail, B., Chanteloup, E., Haaser, M., Darriet, M., Couzigou, P., & de Lédinghen, V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.018 · Cited by 2,487
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Jacobson, I. M., McHutchison, J. G., Dusheiko, G., Di Bisceglie, A. M., Reddy, K. R., Bzowej, N. H., Marcellin, P., Muir, A. J., Ferenci, P., Flisiak, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012912 · Cited by 2,398
Diagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bacon, B. R., Gordon, S. C., Lawitz, E., Marcellin, P., Vierling, J. M., Zeuzem, S., Poordad, F., Goodman, Z. D., Sings, H. L., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009482 · Cited by 1,626
Telaprevir for Retreatment of HCV Infection
Zeuzem, S., Andreone, P., Pol, S., Lawitz, E., Diago, M., Roberts, S., Focaccia, R., Younossi, Z., Foster, G. R., Horban, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013086 · Cited by 1,546
van der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H., Dufour, J.-F., Lammert, F., Duarte-Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., et al. (2012) · JAMA · doi:10.1001/jama.2012.144878 · Cited by 1,510
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Smith, D. B., Bukh, J., Kuiken, C., Muerhoff, S. A., Rice, C. M., Stapleton, J. T., & Simmonds, P. (2014) · Hepatology · doi:10.1002/hep.26744 · Cited by 1,353
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C., & Roudot-Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,341
Evolving epidemiology of hepatitis C virus
Lavanchy, D. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03432.x · Cited by 1,318
Hepatocellular carcinoma: a global view
Yang, J. D., & Roberts, L. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.100 · Cited by 1,286
Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,267
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
McHutchison, J. G., Lawitz, E. J., Shiffman, M. L., Muir, A. J., Galler, G. W., McCone, J., Nyberg, L. M., Lee, W. M., Ghalib, R. H., Schiff, E. R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808010 · Cited by 1,190
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.023 · Cited by 1,088
Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
Arora, S., Thornton, K., Murata, G., Deming, P., Kalishman, S., Dion, D., Parish, B., Burke, T., Pak, W., Dunkelberg, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009370 · Cited by 1,076
Orens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., Egan, T., Keshavjee, S., Knoop, C., Kotloff, R., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.011 · Cited by 1,073
The association between hepatitis C infection and survival after orthotopic liver transplantation
Forman, L. M., Lewis, J. D., Berlin, J. A., Feldman, H. I., & Lucey, M. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32418 · Cited by 1,031
AASLD practice guidelines: Evaluation of the patient for liver transplantation†
Murray, K. F., & Carithers, R. L. (2005) · Hepatology · doi:10.1002/hep.20704 · Cited by 939
Micallef, J. M., Kaldor, J. M., & Dore, G. J. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00651.x · Cited by 871
Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3
Mangia, A., Santoro, R., Minerva, N., Ricci, G. L., Carretta, V., Persico, M., Vinelli, F., Scotto, G., Bacca, D., Annese, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042608 · Cited by 840
Thein, H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008) · Hepatology · doi:10.1002/hep.22375 · Cited by 829
Davis, G. L., Wong, J. B., McHutchison, J. G., Manns, M. P., Harvey, J., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50364 · Cited by 819
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
Sherman, K. E., Flamm, S. L., Afdhal, N. H., Nelson, D. R., Sulkowski, M. S., Everson, G. T., Fried, M. W., Adler, M., Reesink, H. W., Martin, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014463 · Cited by 750
Thompson, A. J., Muir, A. J., Sulkowski, M. S., Ge, D., Fellay, J., Shianna, K. V., Urban, T., Afdhal, N. H., Jacobson, I. M., Esteban, R., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.013 · Cited by 723
Treating viral hepatitis C: efficacy, side effects, and complications
Manns, M. P., Wedemeyer, H., & Cornberg, M. (2006) · Gut · doi:10.1136/gut.2005.076646 · Cited by 659
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1002/hep.1840360730 · Cited by 556
Prieto, M., Berenguer, M., Rayón, J. M., Córdoba, J., Argüello, L., Carrasco, D., García-Herola, A., Olaso, V., De Juan, M., Gobernado, M., et al. (1999) · Hepatology · doi:10.1002/hep.510290122 · Cited by 537
Qurishi, N., Kreuzberg, C., Lüchters, G., Effenberger, W., Kupfer, B., Sauerbruch, T., Rockstroh, J. K., & Spengler, U. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14844-1 · Cited by 525
Gerlach, J. T., Diepolder, H. M., Zachoval, R., Gruener, N. H., Jung, M.-C., Ulsenheimer, A., Schraut, W. W., Schirren, C. A., Waechtler, M., Backmund, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00668-1 · Cited by 524
Hepatitis C virus kinetics during and immediately after liver transplantation
Garcia-Retortillo, M., Forns, X., Feliu, A., Moitinho, E., Costa, J., Navasa, M., Rimola, A., & Rodes, J. (2002) · Hepatology · doi:10.1053/jhep.2002.31773 · Cited by 503
Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3
Shiffman, M. L., Suter, F., Bacon, B. R., Nelson, D., Harley, H., Solá, R., Shafran, S. D., Barange, K., Lin, A., Soman, A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066403 · Cited by 493
The changing epidemiology of hepatitis C virus infection in Europe
Esteban, J. I., Sauleda, S., & Quer, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.033 · Cited by 481
ZEUZEM, S. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.007 · Cited by 448
Eltrombopag for Thrombocytopenia in Patients with Cirrhosis Associated with Hepatitis C
McHutchison, J. G., Dusheiko, G., Shiffman, M. L., Rodriguez-Torres, M., Sigal, S., Bourliere, M., Berg, T., Gordon, S. C., Campbell, F. M., Theodore, D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073255 · Cited by 448
Hézode, C., Fontaine, H., Dorival, C., Larrey, D. G., Zoulim, F., Canva, V., de Lédinghen, V., Poynard, T., Samuel, D., Bourlière, M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.035 · Cited by 443
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Cornberg, M., Razavi, H. A., Alberti, A., Bernasconi, E., Buti, M., Cooper, C., Dalgard, O., Dillion, J. F., Flisiak, R., Forns, X., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02539.x · Cited by 411
Alberti, A., Clumeck, N., Collins, S., Gerlich, W., Lundgren, J., Palù, G., Reiss, P., Thiebaut, R., Weiland, O., Yazdanpanah, Y., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.003 · Cited by 382
Singal, A. G., Volk, M. L., Jensen, D., Di Bisceglie, A. M., & Schoenfeld, P. S. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.11.018 · Cited by 362
Bressler, B. L., Guindi, M., Tomlinson, G., & Heathcote, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50350 · Cited by 358
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy†
Everson, G. T., Trotter, J., Forman, L., Kugelmas, M., Halprin, A., Fey, B., & Ray, C. (2005) · Hepatology · doi:10.1002/hep.20793 · Cited by 357
Carrión, J. A., Navasa, M., García-Retortillo, M., García‐Pagán, J. C., Crespo, G., Bruguera, M., Bosch, J., & Forns, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.041 · Cited by 347
Berenguer, M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.05.002 · Cited by 342
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
Neumann, U. P., Berg, T., Bahra, M., Seehofer, D., Langrehr, J. M., Neuhaus, R., Radke, C., & Neuhaus, P. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.029 · Cited by 339
Swain, M. G., Lai, M., Shiffman, M. L., Cooksley, W. G. E., Zeuzem, S., Dieterich, D. T., Abergel, A., Pessôa, M. G., Lin, A., Tietz, A., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.009 · Cited by 328
Treatment predictors of a sustained virologic response in hepatitis B and C
Kau, A., Vermehren, J., & Sarrazin, C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.013 · Cited by 324
Turner, K. M. E., Hutchinson, S., Vickerman, P., Hope, V., Craine, N., Palmateer, N., May, M., Taylor, A., De Angelis, D., Cameron, S., et al. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03515.x · Cited by 299
Daily Cannabis Smoking as a Risk Factor for Progression of Fibrosis in Chronic Hepatitis C *
Hézode, C., Roudot-Thoraval, F., Nguyen, S., Grenard, P., Julien, B., Zafrani, E.-S., Pawlostky, J.-M., Dhumeaux, D., Lotersztajn, S., & Mallat, A. (2005) · Hepatology · doi:10.1002/hep.20733 · Cited by 293
Blasco, A., Forns, X., Carrión, J. A., García-Pagán, J. C., Gilabert, R., Rimola, A., Miquel, R., Bruguera, M., García-Valdecasas, J.-C., Bosch, J., et al. (2006) · Hepatology · doi:10.1002/hep.21090 · Cited by 293
Role of alcohol in the progression of liver disease caused by hepatitis C virus infection
Ostapowicz, G., Watson, K. J., Locarnini, S. A., & Desmond, P. V. (1998) · Hepatology · doi:10.1002/hep.510270637 · Cited by 286
Berenguer, M., Palau, A., Aguilera, V., Rayón, J.-M., Juan, F. S., & Prieto, M. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02126.x · Cited by 283
Increased Caffeine Consumption Is Associated With Reduced Hepatic Fibrosis
Modi, A. A., Feld, J. J., Park, Y., Kleiner, D. E., Everhart, J. E., Liang, J. T., & Hoofnagle, J. H. (2010) · Hepatology · doi:10.1002/hep.23279 · Cited by 279
Pearlman, B. L., Ehleben, C., & Saifee, S. (2007) · Hepatology · doi:10.1002/hep.21919 · Cited by 269
van de Laar, T. J., Matthews, G. V., Prins, M., & Danta, M. (2010) · AIDS · doi:10.1097/qad.0b013e32833c11a5 · Cited by 252
The history of the “natural history” of hepatitis C (1968–2009)
Seeff, L. B. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01927.x · Cited by 249
Methamphetamine-Related Deaths in San Francisco: Demographic, Pathologic, and Toxicologic Profiles
Karch, S., Stephens, B., & Ho, C.-H. (1999) · Journal of Forensic Sciences · doi:10.1520/jfs14464j · Cited by 248
Surveillance and epidemiology of hepatitis B and C in Europe – a review
Rantala, M., & van de Laar, M. J. (2008) · Eurosurveillance · doi:10.2807/ese.13.21.18880-en · Cited by 245
Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
Hellard, M., Sacks‐Davis, R., & Gold, J. (2009) · Clinical Infectious Diseases · doi:10.1086/600304 · Cited by 232
Martin, N. K., Vickerman, P., Foster, G. R., Hutchinson, S. J., Goldberg, D. J., & Hickman, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.029 · Cited by 230
Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
Schaefer, M., Capuron, L., Friebe, A., Diez-Quevedo, C., Robaeys, G., Neri, S., Foster, G. R., Kautz, A., Forton, D., & Pariante, C. M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.037 · Cited by 225
Hagan, H., Pouget, E. R., Des Jarlais, D. C., & Lelutiu-Weinberger, C. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn237 · Cited by 222
Cost–Effectiveness of Hepatitis C Virus Antiviral Treatment for Injection Drug User Populations
Martin, N. K., Vickerman, P., Miners, A., Foster, G. R., Hutchinson, S. J., Goldberg, D. J., & Hickman, M. (2012) · Hepatology · doi:10.1002/hep.24656 · Cited by 221
Castéra, L., Sebastiani, G., Le Bail, B., de Lédinghen, V., Couzigou, P., & Alberti, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.008 · Cited by 214
Hofer, H., Watkins-Riedel, T., Janata, O., Penner, E., Holzmann, H., Steindl-Munda, P., Gangl, A., & Ferenci, P. (2003) · Hepatology · doi:10.1053/jhep.2003.50019 · Cited by 203
Patrick, D. M., TYNDALL, M. W., Cornelisse, P., Li, K. K., Sherlock, C. H., Rekart, M. L., Strathdee, S. A., Currie, S. L., Schechter, M. T., & O’Shaughnessy, M. V. (2001) · Europe PMC (PubMed Central) · Cited by 203
Novel therapies for hepatitis C — one pill fits all?
Manns, M. P., & von Hahn, T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4050 · Cited by 194
Barriers associated with the treatment of hepatitis C virus infection among illicit drug users
Grebely, J., Genoway, K. A., Raffa, J. D., Dhadwal, G., Rajan, T., Showler, G., Kalousek, K., Duncan, F., Tyndall, M. W., Fraser, C., et al. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.09.008 · Cited by 191
Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C
Hézode, C., Zafrani, E. S., Roudot–Thoraval, F., Costentin, C., Hessami, A., Bouvier–Alias, M., Medkour, F., Pawlostky, J., Lotersztajn, S., & Mallat, A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.039 · Cited by 190
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
Antaki, N., Craxi, A., Kamal, S., Moucari, R., Van der Merwe, S., Haffar, S., Gadano, A., Zein, N., Lai, C. L., Pawlotsky, J.-M., et al. (2010) · Liver International · doi:10.1111/j.1478-3231.2009.02188.x · Cited by 186
Carrión, J. A., Martínez-Bauer, E., Crespo, G., Ramírez, S., Pérez-del-Pulgar, S., García-Valdecasas, J. C., Navasa, M., & Forns, X. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.11.015 · Cited by 185
Romero-Gómez, M., Fernández-Rodríguez, C. M., Andrade, R. J., Diago, M., Alonso, S., Planas, R., Solá, R., Pons, J. A., Salmerón, J., Barcena, R., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.022 · Cited by 185
Ecstasy: A common cause of severe acute hepatotoxicity
Andreu, V., Mas, A., Bruguera, M., Salmerón, J. M., Moreno, V., Nogué, S., & Rodés, J. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80056-1 · Cited by 182
Acute Hepatitis C: A Systematic Review.: CME
Kamal, S. M. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01825.x · Cited by 180
Martinot‐Peignoux, M., Stern, C., Maylin, S., Ripault, M., Boyer, N., Leclere, L., Castelnau, C., Giuily, N., El Ray, A., Cardoso, A., et al. (2010) · Hepatology · doi:10.1002/hep.23444 · Cited by 176
Management of chronic viral hepatitis before and after renal transplantation
Gane, E., & Pilmore, H. (2002) · Transplantation · doi:10.1097/00007890-200208270-00001 · Cited by 175
Laboratory Diagnostics for Hepatitis C Virus Infection
Kamili, S., Drobeniuc, J., Araujo, A. C., & Hayden, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis368 · Cited by 173
Meta‐analysis: interferon for the treatment of chronic hepatitis C in dialysis patients
Fabrizi, F., Dulai, G. S., Dixit, V. K., Bunnapradist, S., & Martin, P. B. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01780.x · Cited by 165
Alcohol Use and Treatment of Hepatitis C Virus: Results of a National Multicenter Study
Anand, B. S., Currie, S., Dieperink, E., Bini, E. J., Shen, H., Ho, S. B., & Wright, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.023 · Cited by 162
The European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel (2010) · AIDS · doi:10.1097/qad.0b013e328343443b · Cited by 162
The hepatitis C virus epidemic among injecting drug users
Pybus, O. G., Cochrane, A., Holmes, E. C., & Simmonds, P. (2005) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2004.08.001 · Cited by 162
What Is Killing People with Hepatitis C Virus Infection?
Grebely, J., & Dore, G. J. (2011) · Seminars in Liver Disease · doi:10.1055/s-0031-1297922 · Cited by 161
Mauss, S., Berger, F., Goelz, J., Jacob, B., & Schmutz, G. (2004) · Hepatology · doi:10.1002/hep.20279 · Cited by 161
Maurer, H. H., Sauer, C., & Theobald, D. S. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000211812.27558.6e · Cited by 149
Review and management of drug interactions with boceprevir and telaprevir
Kiser, J. J., Burton, J. R., Anderson, P. L., & Everson, G. T. (2012) · Hepatology · doi:10.1002/hep.25653 · Cited by 144
Doab, A., Treloar, C., & Dore, G. J. (2005) · Clinical Infectious Diseases · doi:10.1086/427446 · Cited by 144
van Asten, L., Verhaest, I., Lamzira, S., Hernández‐Aguado, I., Zangerle, R., Boufassa, F., Rezza, G., Broers, B., Robertson, R., Brettle, R. P., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/380821 · Cited by 143
Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection
Dore, G. J., Hellard, M. E., Matthews, G. V., Grebely, J., Haber, P., Petoumenos, K., Yeung, B., Marks, P. S., van Beek, I., McCaughan, G. W., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.019 · Cited by 140
Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users
van den Berg, C. H. S. B., Smit, C., Bakker, M. E., Geskus, R. B., Berkhout, B., Jurriaans, S., Coutinho, R. A., Wolthers, K. C., & Prins, M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-006-9089-7 · Cited by 139
Changes in Blood-borne Infection Risk Among Injection Drug Users
Mehta, S. H., Astemborski, J. A., Kirk, G. D., Strathdee, S. A., Nelson, K. E., Vlahov, D., & Thomas, D. L. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq112 · Cited by 133
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
Robaeys, G., Grebely, J., Mauss, S., Bruggmann, P., Moussalli, J., Gottardi, A. D., Swan, T., Arain, A., Kautz, A., Stöver, H., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit302 · Cited by 123
High hepatitis C incidence in new injecting drug users: a policy failure?
Maher, L., Li, J., Jalaludin, B. B., Chant, K. G., & Kaldor, J. M. (2007) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2007.00007.x · Cited by 122
Grebely, J., Knight, E., Genoway, K. A., Viljoen, M., Khara, M., Elliott, D., Gallagher, L., Storms, M. M., Raffa, J. D., DeVlaming, S., et al. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832a8c4c · Cited by 121
Long-Term Methadone Maintenance Therapy: Effects on Liver Function
Kreek, M. J., DODES, L., KANE, S., KNOBLER, J., & MARTIN, R. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-4-598 · Cited by 120
Kanwal, F., Hoang, T., Spiegel, B. M. R., Eisen, S. A., Dominitz, J. A., Gifford, A. L., Goetz, M. B., & Asch, S. M. (2007) · Hepatology · doi:10.1002/hep.21927 · Cited by 120
Vermehren, J., Kau, A., Gärtner, B. C., Göbel, R., Zeuzem, S., & Sarrazin, C. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00755-08 · Cited by 116
Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes
Chevaliez, S., & Pawlotsky, J. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2008.11.004 · Cited by 105
Deterding, K., Grüner, N. H., Buggisch, P., Wiegand, J., Galle, P. R., Spengler, U., Hinrichsen, H. M., Berg, T., Potthoff, A., Malek, N. P., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70059-8 · Cited by 104
Sylvestre, D. L., Litwin, A. H., Clements, B. J., & Gourevitch, M. N. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.06.002 · Cited by 104
Potthoff, A., Wedemeyer, H. H., Boecher, W. O., Berg, T., Zeuzem, S., Arnold, J. C., Spengler, U., Grüngreiff, K., Kaeser, T., Schuchmann, M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.028 · Cited by 99
de Bruijne, J., Schinkel, J., Prins, M., Koekkoek, S. M., Aronson, S. J., van Ballegooijen, M., Reesink, H. W., Molenkamp, R., & van de Laar, T. J. W. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01146-09 · Cited by 98
Integrating HCV services for drug users: A model to improve engagement and outcomes
Sylvestre, D. L., & Zweben, J. E. (2007) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2007.01.010 · Cited by 97
Selzner, N., Guindi, M. M., Renner, E. L., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.012 · Cited by 97
Reinfection with hepatitis C virus following sustained virological response in injection drug users
Grebely, J., Knight, E., Ngai, T., Genoway, K. A., Raffa, J. D., Storms, M. M., Gallagher, L., Krajden, M., Dore, G. J., Duncan, F., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06238.x · Cited by 94
High hepatitis C virus prevalence and incidence among Canadian intravenous drug users
Roy, É., Alary, M., Morissette, C., Leclerc, P., Boudreau, J., Parent, R., Rochefort, J., Claessens, C., & The SurvUDI Working Group (2007) · International Journal of STD & AIDS · doi:10.1258/095646207779949880 · Cited by 92
Environmental factors as disease accelerators during chronic hepatitis C
Mallat, A., Hézode, C., & Lotersztajn, S. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.004 · Cited by 86
Grebely, J., Raffa, J. D., Meagher, C., Duncan, F., Genoway, K. A., Khara, M., McLean, M., Mead, A., Viljoen, M., DeVlaming, S., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05032.x · Cited by 83
Robaeys, G., Vlierberghe, H. V., Mathe, C., Ranst, M. A. V., & Bruckers, L. M. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200602000-00008 · Cited by 80
Elevated Liver Enzyme Levels in Opioid‐Dependent Patients with Hepatitis Treated with Buprenorphine
Petry, N. M., Bickel, W. K., Piasecki, D. P., Marsch, L. A., & Badger, G. J. (2000) · American Journal on Addictions · doi:10.1080/10550490050148099 · Cited by 79
Darke, S. G., Kaye, S. S., & Duflou, J. A. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01601.x · Cited by 77
Acute hepatitis C: diagnosis and management
Mondelli, M. U., Cerino, A., & Cividini, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.017 · Cited by 76
Marcellin, P., Chousterman, M., Fontanges, T., Ouzan, D., Rotily, M., Varastet, M., Lang, J.-P., Melin, P., Cacoub, P., & for the CheObs Study Group (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02461.x · Cited by 75
Kramer, J. R., Kanwal, F., Richardson, P. A., Giordano, T. P., Petersen, L. A., & El‐Serag, H. B. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.430 · Cited by 75
Siu, L., Foont, J., & Wands, J. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1214374 · Cited by 74
Marijuana Use in Potential Liver Transplant Candidates
Ranney, D. N., Acker, W. B., Al‐Holou, S. N., Ehrlichman, L. K., Lee, D. S., Lewin, S. A., Nguyen, C., Peterson, S. F., Sell, K., Kubus, J. J., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02468.x · Cited by 73
Serfaty, L., Forns, X., Goeser, T., Ferenci, P., Nevens, F., Carosi, G., Drenth, J. P. H., Lonjon‐Domanec, I., DeMasi, R. A., Picchio, G., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300749 · Cited by 73
Bruggmann, P., Falcato, L., Dober, S., Helbling, B., Keiser, O., Negro, F., Meili, D., & Study, O. B. O. T. S. H. C. C. (2008) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01010.x · Cited by 73
Mortality in heroin-assisted treatment in Switzerland 1994–2000
Rehm, J. T., Frick, U., Hartwig, C., Gutzwiller, F. F., Gschwend, P., & Uchtenhagen, A. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.01.005 · Cited by 70
Evon, D. M., Simpson, K. M. J., Kixmiller, S., Galanko, J. A., Dougherty, K. A., Golin, C. E., & Fried, M. W. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.219 · Cited by 68
Association of caffeine intake and histological features of chronic hepatitis C
Costentin, C. E., Roudot‐Thoraval, F., Zafrani, E., Medkour, F., Pawlotsky, J., Mallat, A., & Hézode, C. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.027 · Cited by 68
Liver Transplantation and Opioid Dependence
Koch, M. (2001) · JAMA · doi:10.1001/jama.285.8.1056 · Cited by 68
Brunet, L., Moodie, E. E. M., Rollet, K., Cooper, C., Walmsley, S. L., Potter, M., Klein, M. B., & for the Canadian Co-infection Cohort Investigators (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit378 · Cited by 67
Rodriguez‐Torres, M., Slim, J., Bhatti, L., Sterling, R. K., Sulkowski, M., Hassanein, T., Serrão, R., Sola, R. L., Bertasso, A., Passe, A. S., et al. (2012) · HIV Clinical Trials · doi:10.1310/hct1303-142 · Cited by 65
Survival and Risk of Recidivism in Methadone-Dependent Patients Undergoing Liver Transplantation
Liu, L. U., Schiano, T. D., Lau, N., O'Rourke, M., Min, A. D., Sigal, S. H., Drooker, M., & Bodenheimer, H. C. (2003) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00199.x · Cited by 65
Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting
Kim, C., Kerr, T. H., Li, K. K., Zhang, R., TYNDALL, M. W., Montaner, J. S. G., & Wood, E. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-270 · Cited by 65
Currie, S. L., Ryan, J. C., Tracy, D., Wright, T. L., George, S., McQuaid, R., Kim, M., Shen, H., & Monto, A. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.09.011 · Cited by 63
Ohfuji, S., Fukushima, W., Tanaka, T., Habu, D., Tamori, A., SAKAGUCHI, H., Takeda, T., Kawada, N., Seki, S., & Nishiguchi, S. (2006) · Hepatology Research · doi:10.1016/j.hepres.2006.07.010 · Cited by 62
Grebely, J., Raffa, J., Lai, C., Kerr, T., Fischer, B., Krajden, M., Dore, G., & Tyndall, M. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01279.x · Cited by 60
Weiss, J. J., Bräu, N., Stivala, A. C., Swan, T., & Fishbein, D. A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04004.x · Cited by 60
Grebely, J., Matthews, G. V., Hellard, M. E., Shaw, D., van Beek, I., Petoumenos, K., Alavi, M., Yeung, B., Haber, P., Lloyd, A. R., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.033 · Cited by 59
Assessing the Validity of Self-Reported Medication Adherence in Hepatitis C Treatment
Smith, S. R., Wahed, A. S., Kelley, S. S., Conjeevaram, H. S., Robuck, P. R., & Fried, M. W. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k024 · Cited by 57
Harrison, S. A., Hamzeh, F. M., Han, J., Pandya, P., Sheikh, M. Y., & Vierling, J. M. (2012) · Hepatology · doi:10.1002/hep.25661 · Cited by 57
Manns, M. P., Zeuzem, S., Sood, A., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.024 · Cited by 57
Bruggmann, P., Dampz, M., Gerlach, T., Kravecz, L., & Falcato, L. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.02.016 · Cited by 50
John‐Baptiste, A., Krahn, M. D., Heathcote, J., Laporte, A., & TOMLINSON, G. A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.015 · Cited by 47
Interferon for acute hepatitis C
Myers, R. P., Regimbeau, C., Thévenot, T., Leroy, V., Mathurin, P., Opolon, P., Zarski, J., & Poynard, T. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000369 · Cited by 45
Alvarez‐Uria, G., Day, J., Jafar, A. J. N., Russell, S. K., & Vilar, F. J. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01958.x · Cited by 44
Bonkovsky, H. L., Tice, A. D., Yapp, R. G., Bodenheimer, H. C., Monto, A., Rossi, S. J., & Sulkowski, M. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02065.x · Cited by 42
Larrey, D. G., Salse, A., Ribard, D., Boutet, O., Hyrailles, V., Niang, B., Pageaux, G., Vaucher, E., Arpurt, J. P., Boulay, G., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.05.022 · Cited by 41
Lan, C. L., Guillygomarc’h, A., Danielou, H., Dréau, G. L., Lainé, F., Vedeilhie, C., Deugnier, Y., Brissot, P., Guyader, D., & Moirand, R. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.021 · Cited by 35
Rodis, J. L., & Kibbe, P. J. (2010) · Gastroenterology Nursing · doi:10.1097/sga.0b013e3181f443cb · Cited by 31
Waizmann, M., & Ackermann, G. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.02.002 · Cited by 31
Weiss, J. J., Alcorn, M. C., Rabkin, J. G., & Dieterich, D. T. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.014 · Cited by 24
Does Information about IDUs' Injecting Networks Predict Exposure to the Hepatitis C Virus?
Aitken, C. K., Lewis, J. A., Hocking, J. S., Bowden, D. S., & Hellard, M. E. (2009) · Hepatitis Monthly · Cited by 19
Alavian, S. M., Tabatabaei, S. V., & Behnava, B. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01532.x · Cited by 17
Bruneau, J., Daniel, M., Kestens, Y., Abrahamowicz, M., & Zang, G. (2010) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2010.05.001 · Cited by 16
Illicit drug use and liver transplantation: is there a problem and what is the solution?
Webb, K., Shepherd, L., & Neuberger, J. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00724.x · Cited by 15
Stickel, F., Helbling, B., Heim, M. H., Geier, A., Hirschi, C., Beretta‐Piccoli, B. T., Wehr, K., Gottardi, A. D., Negro, F., & Gerlach, T. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01527.x · Cited by 15
Gottardi, A. D., Hilleret, M., Gelez, P., Mura, V. L., Guillaud, O., Majno, P. E., Hadengue, A., Morel, P., Zarski, J., Fontana, M., et al. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2009.01121.x · Cited by 11
New thrombopoietin receptor agonists for platelet disorders
Homeida, S., Ebdon, C., Batty, P. A., Jackson, B., Kolade, S. O., Bateman, C. M., Peng, Y., & Stasi, R. (2012) · Drugs of today · doi:10.1358/dot.2012.48.4.1740505 · Cited by 11
Cited by
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.006 · Cited by 1,875
EASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
EASL Recommendations on Treatment of Hepatitis C 2015
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.025 · Cited by 1,156
EASL Recommendations on Treatment of Hepatitis C 2016
(2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.001 · Cited by 985
Metadata
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 60
- Issue
- 2
- Pages
- 392-420
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4210961054
- Cited by
- 855
- References
- 154
- FWCI
- 91.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.